| Autor: |
Moretti M; Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.; European Study Group for Legionella Infections (ESGLI), 4051 Basel, Switzerland., Van Nedervelde J; Independent Researcher in Primary Care, 6222 Villers-la-Ville, Belgium., Vanstokstraeten R; Department of Microbiology and Infection Control, National Reference Centre for Legionella pneumophila, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium., Seyler L; Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium., Echahidi F; European Study Group for Legionella Infections (ESGLI), 4051 Basel, Switzerland.; Department of Microbiology and Infection Control, National Reference Centre for Legionella pneumophila, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium., Prevost B; National Reference Centre for Legionella pneumophila, Laboratoires des Hôpitaux Universitaires de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), 1000 Brussels, Belgium., Martiny D; National Reference Centre for Legionella pneumophila, Laboratoires des Hôpitaux Universitaires de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), 1000 Brussels, Belgium., Wybo I; European Study Group for Legionella Infections (ESGLI), 4051 Basel, Switzerland.; Department of Microbiology and Infection Control, National Reference Centre for Legionella pneumophila, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium., Michel C; European Study Group for Legionella Infections (ESGLI), 4051 Basel, Switzerland.; Department of Microbiology and Infection Control, National Reference Centre for Legionella pneumophila, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium. |
| Abstrakt: |
Background : The incidence of Legionnaires' disease (LD) is increasing steadily in Europe. Its early diagnosis by general practitioners (GPs) is crucial for better patient outcomes. Study objectives : This study assessed Belgian GPs' knowledge about LD and the accessibility of diagnostic tests in their practices. Methods : A specifically designed questionnaire was distributed to actively practicing GPs, including primary care trainees, between 31 January 2022 and 13 March 2022. This survey targeted approximately 4200 GPs with an estimated population catchment of 30% of the actively working Belgian GPs. Results : The response rate was estimated at 3%. Over 70% of the GPs correctly identified the LD occurrence peak, major risk factors, and clinical manifestations. While 62% of participants preferred the Legionella pneumophila urinary antigen test (UAT) as a primary diagnostic method, 75% were unsure about its availability within their laboratories and 82% had not prescribed it in the last year. Finally, 76% expressed a desire for additional information on this topic. Conclusions : Belgian GPs should evaluate the possibility of conducting UAT testing in their laboratories to enhance LD case management and improve their preparedness. Furthermore, initiatives should be implemented to improve communication between specialists and GPs and develop educational programs directed at Belgian GPs. |
